Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 316

1.

Effects and costs of implementing predictive risk stratification in primary care: a randomised stepped wedge trial.

Snooks H, Bailey-Jones K, Burge-Jones D, Dale J, Davies J, Evans BA, Farr A, Fitzsimmons D, Heaven M, Howson H, Hutchings H, John G, Kingston M, Lewis L, Phillips C, Porter A, Sewell B, Warm D, Watkins A, Whitman S, Williams V, Russell I.

BMJ Qual Saf. 2018 Nov 5. pii: bmjqs-2018-007976. doi: 10.1136/bmjqs-2018-007976. [Epub ahead of print]

2.

The European Respiratory Society: ensuring excellence through education best practice.

Farr A, Gaga M, Welte T, Troosters T, Joos G, Robalo Cordeiro C, Burghuber OC, Brusselle G, Gratziou CG, Bush A, Saraiva I, Pannetier C, Stolz D.

Eur Respir J. 2018 Sep 15;52(3). pii: 1801248. doi: 10.1183/13993003.01248-2018. Print 2018 Sep. No abstract available.

PMID:
30219751
3.

Impact of fetal maceration grade on risk of maternal disseminated intravascular coagulation after intrauterine fetal death - A retrospective cohort study.

Muin DA, Haslacher H, Koller V, Kiss H, Scharrer A, Farr A.

Sci Rep. 2018 Aug 24;8(1):12742. doi: 10.1038/s41598-018-30687-0.

4.

ERS Congress highlight: educational forum on continuing professional development.

Sehlbach C, Farr A, Allen M, Guiral JG, Wielders PLML, Stolz D, Rohde G.

Breathe (Sheff). 2018 Jun;14(2):e12-e16. doi: 10.1183/20734735.020918.

5.

Placentophagy among women planning community births in the United States: Frequency, rationale, and associated neonatal outcomes.

Farr A, Chervenak FA, McCullough LB, Grünebaum A, Benyshek DC, Cheyney MM, Bovbjerg ML.

Birth. 2018 Jul 29. doi: 10.1111/birt.12375. [Epub ahead of print] No abstract available.

PMID:
30058077
6.

Evaluation of Reproductive Concerns and Biographical Impact of Breast Cancer in Young Patients.

Burgmann M, Hermelink K, Farr A, van Meegen F, Heiduschk A, Engel J, Kolben T, Degenhardt T, Ditsch N, Mahner S, Harbeck N, Würstlein R.

Breast Care (Basel). 2018 Apr;13(2):126-130. doi: 10.1159/000481340. Epub 2018 Feb 1.

PMID:
29887790
7.

MRI-based quantification of residual fibroglandular tissue of the breast after conservative mastectomies.

Woitek R, Pfeiler G, Farr A, Kapetas P, Furtner J, Bernathova M, Schöpf V, Clauser P, Marino MA, Pinker K, Baltzer PA, Helbich TH.

Eur J Radiol. 2018 Jul;104:1-7. doi: 10.1016/j.ejrad.2018.04.028. Epub 2018 Apr 26.

PMID:
29857853
8.

An sFlt-1:PlGF ratio of 655 is not a reliable cut-off value for predicting perinatal outcomes in women with preeclampsia.

Stolz M, Zeisler H, Heinzl F, Binder J, Farr A.

Pregnancy Hypertens. 2018 Jan;11:54-60. doi: 10.1016/j.preghy.2018.01.001. Epub 2018 Jan 2.

PMID:
29523274
9.

Adverse Events of Trastuzumab Emtansine (T-DM1) in the Treatment of HER2-Positive Breast Cancer Patients.

Kowalczyk L, Bartsch R, Singer CF, Farr A.

Breast Care (Basel). 2017 Dec;12(6):401-408. doi: 10.1159/000480492. Epub 2017 Dec 3. Review.

PMID:
29456473
10.

Quality of web-based family-building information for LGBTQ individuals.

Kreines FM, Farr A, Chervenak FA, Grünebaum A.

Eur J Contracept Reprod Health Care. 2018 Feb;23(1):18-23. doi: 10.1080/13625187.2018.1432036. Epub 2018 Feb 13.

PMID:
29436869
11.

Predictive risk stratification model: a randomised stepped-wedge trial in primary care (PRISMATIC).

Snooks H, Bailey-Jones K, Burge-Jones D, Dale J, Davies J, Evans B, Farr A, Fitzsimmons D, Harrison J, Heaven M, Howson H, Hutchings H, John G, Kingston M, Lewis L, Phillips C, Porter A, Sewell B, Warm D, Watkins A, Whitman S, Williams V, Russell IT.

Southampton (UK): NIHR Journals Library; 2018 Jan.

12.

Influence of Orally Administered Probiotic Lactobacillus Strains on Vaginal Microbiota in Women with Breast Cancer during Chemotherapy: A Randomized Placebo-Controlled Double-Blinded Pilot Study.

Marschalek J, Farr A, Marschalek ML, Domig KJ, Kneifel W, Singer CF, Kiss H, Petricevic L.

Breast Care (Basel). 2017 Oct;12(5):335-339. doi: 10.1159/000478994. Epub 2017 Oct 27.

13.

Facet-joint injections for non-specific low back pain: a feasibility RCT.

Snidvongs S, Taylor RS, Ahmad A, Thomson S, Sharma M, Farr A, Fitzsimmons D, Poulton S, Mehta V, Langford R.

Health Technol Assess. 2017 Dec;21(74):1-130. doi: 10.3310/hta21740.

14.

Adaptive evolution by spontaneous domain fusion and protein relocalization.

Farr AD, Remigi P, Rainey PB.

Nat Ecol Evol. 2017 Oct;1(10):1562-1568. doi: 10.1038/s41559-017-0283-7. Epub 2017 Aug 28.

PMID:
29185504
15.

Darwin was right: where now for experimental evolution?

Rainey PB, Remigi P, Farr AD, Lind PA.

Curr Opin Genet Dev. 2017 Dec;47:102-109. doi: 10.1016/j.gde.2017.09.003. Epub 2017 Oct 20. Review.

PMID:
29059583
16.

Human placentophagy: a review.

Farr A, Chervenak FA, McCullough LB, Baergen RN, Grünebaum A.

Am J Obstet Gynecol. 2018 Apr;218(4):401.e1-401.e11. doi: 10.1016/j.ajog.2017.08.016. Epub 2017 Aug 30. Review.

PMID:
28859955
17.

Evaluation of the effectiveness and cost-effectiveness of lightweight fibreglass heel casts in the management of ulcers of the heel in diabetes: a randomised controlled trial.

Jeffcoate W, Game F, Turtle-Savage V, Musgrove A, Price P, Tan W, Bradshaw L, Montgomery A, Fitzsimmons D, Farr A, Winfield T, Phillips C.

Health Technol Assess. 2017 May;21(34):1-92. doi: 10.3310/hta21340.

18.

Meloxicam ameliorates the cartilage and subchondral bone deterioration in monoiodoacetate-induced rat osteoarthritis.

Nagy E, Vajda E, Vari C, Sipka S, Fárr AM, Horváth E.

PeerJ. 2017 Apr 12;5:e3185. doi: 10.7717/peerj.3185. eCollection 2017.

19.

The effect of obesity on pathological complete response and survival in breast cancer patients receiving uncapped doses of neoadjuvant anthracycline-taxane-based chemotherapy.

Farr A, Stolz M, Baumann L, Bago-Horvath Z, Oppolzer E, Pfeiler G, Seifert M, Singer CF.

Breast. 2017 Jun;33:153-158. doi: 10.1016/j.breast.2017.04.001. Epub 2017 Apr 7.

PMID:
28395233
20.

The colonization with Candida species is more harmful in the second trimester of pregnancy.

Holzer I, Farr A, Kiss H, Hagmann M, Petricevic L.

Arch Gynecol Obstet. 2017 Apr;295(4):891-895. doi: 10.1007/s00404-017-4331-y. Epub 2017 Mar 3.

21.

Endobronchial ultrasound: launch of an ERS structured training programme.

Farr A, Clementsen P, Herth F, Konge L, Rohde G, Dowsland S, Schuhmann M, Annema J.

Breathe (Sheff). 2016 Sep;12(3):217-220. doi: 10.1183/20734735.013116.

22.

Outcomes and trends of peripartum maternal admission to the intensive care unit.

Farr A, Lenz-Gebhart A, Einig S, Ortner C, Holzer I, Elhenicky M, Husslein PW, Lehner R.

Wien Klin Wochenschr. 2017 Sep;129(17-18):605-611. doi: 10.1007/s00508-016-1161-z. Epub 2017 Jan 18.

23.

Effect of delivery mode on neonatal outcome among preterm infants: an observational study.

Holzer I, Lehner R, Ristl R, Husslein PW, Berger A, Farr A.

Wien Klin Wochenschr. 2017 Sep;129(17-18):612-617. doi: 10.1007/s00508-016-1150-2. Epub 2016 Dec 21.

24.

Evolutionary convergence in experimental Pseudomonas populations.

Lind PA, Farr AD, Rainey PB.

ISME J. 2017 Mar;11(3):589-600. doi: 10.1038/ismej.2016.157. Epub 2016 Dec 2.

25.

Prenatal diagnosis of congenital upper limb differences: a current concept review.

Alrabai HM, Farr A, Bettelheim D, Weber M, Farr S.

J Matern Fetal Neonatal Med. 2017 Nov;30(21):2557-2563. doi: 10.1080/14767058.2016.1256989. Epub 2016 Nov 22. Review.

PMID:
27809626
26.

The association between maternal hydronephrosis and acute flank pain during pregnancy: a prospective pilot-study.

Farr A, Ott J, Kueronya V, Margreiter M, Javadli E, Einig S, Husslein PW, Bancher-Todesca D.

J Matern Fetal Neonatal Med. 2017 Oct;30(20):2417-2421. doi: 10.1080/14767058.2016.1252328. Epub 2016 Nov 21.

PMID:
27806658
27.

Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.

McLaurin KK, Farr AM, Wade SW, Diakun DR, Stewart DL.

J Perinatol. 2016 Nov;36(11):990-996. doi: 10.1038/jp.2016.113. Epub 2016 Aug 4.

28.

Erratum to: Risk of cardiovascular events among patients with HIV treated with atazanavircontaining regimens: a retrospective cohort study.

Rosenblatt L, Farr AM, Nkhoma ET, Nelson JK, Ritchings C, Johnston SS.

BMC Infect Dis. 2016 Oct 7;16(1):547. No abstract available.

29.

Risk of cardiovascular events among patients with HIV treated with atazanavir-containing regimens: a retrospective cohort study.

Rosenblatt L, Farr AM, Nkhoma ET, Nelson JK, Ritchings C, Johnston SS.

BMC Infect Dis. 2016 Sep 19;16:492. doi: 10.1186/s12879-016-1827-1. Erratum in: BMC Infect Dis. 2016 Oct 7;16(1):547.

30.

The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases.

Mukherjee M, Stoddart A, Gupta RP, Nwaru BI, Farr A, Heaven M, Fitzsimmons D, Bandyopadhyay A, Aftab C, Simpson CR, Lyons RA, Fischbacher C, Dibben C, Shields MD, Phillips CJ, Strachan DP, Davies GA, McKinstry B, Sheikh A.

BMC Med. 2016 Aug 29;14(1):113. doi: 10.1186/s12916-016-0657-8.

31.

Adverse Mucocutaneous Reaction to Pertuzumab in a Patient with HER2-Positive Metastatic Breast Cancer.

Kowalczyk L, Singer CF, Staudigl C, Weber M, Farr A.

Breast J. 2017 May;23(3):352-353. doi: 10.1111/tbj.12676. Epub 2016 Aug 26. No abstract available.

PMID:
27563723
32.

Comparison of adherence and persistence among adults with type 2 diabetes mellitus initiating saxagliptin or linagliptin.

Farr AM, Sheehan JJ, Davis BM, Smith DM.

Patient Prefer Adherence. 2016 Aug 5;10:1471-9. doi: 10.2147/PPA.S112598. eCollection 2016.

33.

Evaluation of the vaginal flora in pregnant women receiving opioid maintenance therapy: a matched case-control study.

Farr A, Kiss H, Hagmann M, Holzer I, Kueronya V, Husslein PW, Petricevic L.

BMC Pregnancy Childbirth. 2016 Aug 5;16(1):206. doi: 10.1186/s12884-016-1003-z.

34.

Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US.

Miller JD, Ye X, Lenhart GM, Farr AM, Tran OV, Kwong WJ, Magnuson EA, Weintraub WS.

Clinicoecon Outcomes Res. 2016 May 20;8:215-26. doi: 10.2147/CEOR.S98888. eCollection 2016.

35.

Bacterial Peptidoglycan Traverses the Placenta to Induce Fetal Neuroproliferation and Aberrant Postnatal Behavior.

Humann J, Mann B, Gao G, Moresco P, Ramahi J, Loh LN, Farr A, Hu Y, Durick-Eder K, Fillon SA, Smeyne RJ, Tuomanen EI.

Cell Host Microbe. 2016 Jun 8;19(6):901. doi: 10.1016/j.chom.2016.05.017. No abstract available.

36.

The Lymphatic Endothelial mCLCA1 Antibody Induces Proliferation and Growth of Lymph Node Lymphatic Sinuses.

Jordan-Williams KL, Ramanujam N, Farr AG, Ruddell A.

PLoS One. 2016 May 25;11(5):e0156079. doi: 10.1371/journal.pone.0156079. eCollection 2016.

37.

Risk of Cardiovascular Events Among Patients Initiating Efavirenz-Containing Versus Efavirenz-Free Antiretroviral Regimens.

Rosenblatt L, Farr AM, Johnston SS, Nkhoma ET.

Open Forum Infect Dis. 2016 Mar 30;3(2):ofw061. doi: 10.1093/ofid/ofw061. eCollection 2016 Mar.

38.

Risk of Vaginal Infections at Early Gestation in Patients with Diabetic Conditions during Pregnancy: A Retrospective Cohort Study.

Marschalek J, Farr A, Kiss H, Hagmann M, Göbl CS, Trofaier ML, Kueronya V, Petricevic L.

PLoS One. 2016 May 11;11(5):e0155182. doi: 10.1371/journal.pone.0155182. eCollection 2016.

39.

Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy.

Soliman AM, Bonafede M, Farr AM, Castelli-Haley J, Winkel C.

J Manag Care Spec Pharm. 2016 May;22(5):573-87. doi: 10.18553/jmcp.2016.22.5.573.

40.

Analysis of subsequent surgery rates among endometriosis patients who underwent surgery with and without concomitant leuprolide acetate therapy.

Soliman AM, Bonafede M, Farr AM, Castelli-Haley J, Winkel C.

Curr Med Res Opin. 2016 Jun;32(6):1073-82. doi: 10.1185/03007995.2016.1159189. Epub 2016 Mar 30.

PMID:
27027333
41.

Quantitative Sodium MR Imaging at 7 T: Initial Results and Comparison with Diffusion-weighted Imaging in Patients with Breast Tumors.

Zaric O, Pinker K, Zbyn S, Strasser B, Robinson S, Minarikova L, Gruber S, Farr A, Singer C, Helbich TH, Trattnig S, Bogner W.

Radiology. 2016 Jul;280(1):39-48. doi: 10.1148/radiol.2016151304. Epub 2016 Jan 27.

PMID:
27007803
42.

Bacterial Peptidoglycan Traverses the Placenta to Induce Fetal Neuroproliferation and Aberrant Postnatal Behavior

Humann J, Mann B, Gao G, Moresco P, Ramahi J, Loh LN, Farr A, Hu Y, Durick-Eder K, Fillon SA, Smeyne RJ, Tuomanen EI.

Cell Host Microbe. 2016 Mar 9;19(3):388-99. doi: 10.1016/j.chom.2016.02.009. Erratum in: Cell Host Microbe. 2016 Jun 8;19(6):901.

43.

No Evidence of an Association Between Efavirenz Exposure and Suicidality Among HIV Patients Initiating Antiretroviral Therapy in a Retrospective Cohort Study of Real World Data.

Nkhoma ET, Coumbis J, Farr AM, Johnston SS, Chu BC, Rosenblatt LC, Seekins D, Villasis-Keever A.

Medicine (Baltimore). 2016 Jan;95(3):e2480. doi: 10.1097/MD.0000000000002480.

44.

Healthcare Costs Among Adults with Type 2 Diabetes Initiating DPP-4 Inhibitors.

Farr AM, Sheehan JJ, Brouillette M, Smith DM, Johnston SS, Kalsekar I.

Adv Ther. 2016 Jan;33(1):68-81. doi: 10.1007/s12325-015-0277-2. Epub 2016 Jan 2.

45.

The impact of persistence with therapy on inpatient admissions and emergency room visits in the US among patients with multiple sclerosis.

Thomas NP, Curkendall S, Farr AM, Yu E, Hurley D.

J Med Econ. 2016;19(5):497-505. doi: 10.3111/13696998.2015.1134546. Epub 2016 Jan 18.

PMID:
26706292
46.

Clinical and Economic Outcomes Associated With the Timing of Initiation of Basal Insulin in Patients With Type 2 Diabetes Mellitus Previously Treated With Oral Antidiabetes Drugs.

Levin P, Zhou S, Durden E, Farr AM, Gill J, Wei W.

Clin Ther. 2016 Jan 1;38(1):110-21. doi: 10.1016/j.clinthera.2015.11.011. Epub 2015 Dec 8.

47.

Role of Lactobacillus Species in the Intermediate Vaginal Flora in Early Pregnancy: A Retrospective Cohort Study.

Farr A, Kiss H, Hagmann M, Machal S, Holzer I, Kueronya V, Husslein PW, Petricevic L.

PLoS One. 2015 Dec 11;10(12):e0144181. doi: 10.1371/journal.pone.0144181. eCollection 2015.

48.

Persistence, adherence, and all-cause healthcare costs in atazanavir- and darunavir-treated patients with human immunodeficiency virus in a real-world setting.

Farr AM, Johnston SS, Ritchings C, Brouillette M, Rosenblatt L.

J Med Econ. 2016;19(4):386-96. doi: 10.3111/13696998.2015.1128942. Epub 2015 Dec 29.

PMID:
26640980
49.

Comparison Of Treatment-Related Adverse Events Recorded In Administrative Claims Data With Those Recorded In Electronic Medical Records For Multiple Myeloma Patients.

Irwin DE, Varker H, Farr AM.

Value Health. 2015 Nov;18(7):A683. doi: 10.1016/j.jval.2015.09.2523. Epub 2015 Oct 20. No abstract available.

50.

Treatment Sequencing Patterns And Costs of Care in Patients with Relapsed/Refractory Multiple Myeloma.

Potluri R, Farr AM, Hirji I, Davis C, Bhandari H, Oukessou A.

Value Health. 2015 Nov;18(7):A450. doi: 10.1016/j.jval.2015.09.1134. Epub 2015 Oct 20. No abstract available.

Supplemental Content

Support Center